Abcellera Biologicsinc Stock Technical Analysis
| ABCL Stock | USD 3.90 0.07 1.76% |
As of the 24th of April, Abcellera BiologicsInc shows the mean deviation of 2.46, and Risk Adjusted Performance of (0.06). Abcellera BiologicsInc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down thirteen technical drivers for Abcellera BiologicsInc, which can be compared to its peers. Please confirm Abcellera BiologicsInc information ratio, and the relationship between the coefficient of variation and value at risk to decide if Abcellera BiologicsInc is priced correctly, providing market reflects its regular price of 3.9 per share. Given that Abcellera BiologicsInc has information ratio of (0.15), we suggest you to validate Abcellera BiologicsInc's prevailing market performance to make sure the company can sustain itself at a future point.
Abcellera BiologicsInc Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Abcellera, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AbcelleraAbcellera |
Abcellera BiologicsInc Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 23.88 | Strong Buy | 9 | Odds |
Most Abcellera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abcellera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abcellera BiologicsInc, talking to its executives and customers, or listening to Abcellera conference calls.
Abcellera BiologicsInc technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Abcellera BiologicsInc Technical Analysis
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Abcellera BiologicsInc volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Abcellera BiologicsInc Trend Analysis
Use this graph to draw trend lines for Abcellera BiologicsInc. You can use it to identify possible trend reversals for Abcellera BiologicsInc as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Abcellera BiologicsInc price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Abcellera BiologicsInc Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Abcellera BiologicsInc applied against its price change over selected period. The best fit line has a slop of 0.02 , which may suggest that Abcellera BiologicsInc market price will keep on failing further. It has 122 observation points and a regression sum of squares at 18.13, which is the sum of squared deviations for the predicted Abcellera BiologicsInc price change compared to its average price change.About Abcellera BiologicsInc Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Abcellera BiologicsInc on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Abcellera BiologicsInc based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Abcellera BiologicsInc price pattern first instead of the macroeconomic environment surrounding Abcellera BiologicsInc. By analyzing Abcellera BiologicsInc's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Abcellera BiologicsInc's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Abcellera BiologicsInc specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 156.21 | 29.02 | 618.0 | 648.9 | PTB Ratio | 3.84 | 2.34 | 1.43 | 1.36 |
Abcellera BiologicsInc April 24, 2024 Technical Indicators
Most technical analysis of Abcellera help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Abcellera from various momentum indicators to cycle indicators. When you analyze Abcellera charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.06) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 2.46 | |||
| Coefficient Of Variation | (865.75) | |||
| Standard Deviation | 3.19 | |||
| Variance | 10.2 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.58) | |||
| Total Risk Alpha | (0.82) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 16.27 | |||
| Value At Risk | (5.71) | |||
| Potential Upside | 5.08 | |||
| Skewness | (0.19) | |||
| Kurtosis | 0.1955 |
Abcellera BiologicsInc April 24, 2024 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Abcellera stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 135,451 | ||
| Daily Balance Of Power | (0.19) | ||
| Rate Of Daily Change | 0.98 | ||
| Day Median Price | 4.07 | ||
| Day Typical Price | 4.01 | ||
| Price Action Indicator | (0.21) |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abcellera BiologicsInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.Note that the Abcellera BiologicsInc information on this page should be used as a complementary analysis to other Abcellera BiologicsInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for Abcellera Stock analysis
When running Abcellera BiologicsInc's price analysis, check to measure Abcellera BiologicsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abcellera BiologicsInc is operating at the current time. Most of Abcellera BiologicsInc's value examination focuses on studying past and present price action to predict the probability of Abcellera BiologicsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abcellera BiologicsInc's price. Additionally, you may evaluate how the addition of Abcellera BiologicsInc to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is Abcellera BiologicsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera BiologicsInc. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera BiologicsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.51) | Revenue Per Share 0.131 | Quarterly Revenue Growth (0.57) | Return On Assets (0.1) |
The market value of Abcellera BiologicsInc is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera BiologicsInc's value that differs from its market value or its book value, called intrinsic value, which is Abcellera BiologicsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera BiologicsInc's market value can be influenced by many factors that don't directly affect Abcellera BiologicsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera BiologicsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera BiologicsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera BiologicsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.